NCT05004519View on ClinicalTrials.gov

Benefits of Opioid Free Anesthesia on Morphine Consumption in Gastric Bypass

NACompletedINTERVENTIONAL
Enrollment

183

Participants

Timeline

Start Date

October 5, 2021

Primary Completion Date

September 15, 2022

Study Completion Date

October 15, 2022

Conditions
Analgesics, Opioid
Interventions
DRUG

Dexmedetomidine Injection [Precedex]

dexmedetomidine or remifentanil during laparoscopic gastric bypass

DRUG

Remifentanil

dexmedetomidine or remifentanil during laparoscopic gastric bypass

Trial Locations (1)

1160

CHIREC Delta Hospital, Brussels

All Listed Sponsors
lead

matthieu clanet

OTHER

NCT05004519 - Benefits of Opioid Free Anesthesia on Morphine Consumption in Gastric Bypass | Biotech Hunter | Biotech Hunter